Eric J. Friedman
Director · INTEGRATED BIOPHARMA INC
Individual
- 2025
- Jun 25, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Eric J. Friedman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $69.43M in VOR purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric J. Friedman?
Eric J. Friedman is a corporate insider, tracked as Director of INTEGRATED BIOPHARMA INC (INBP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Eric J. Friedman last file a Form 4?
The most recent primary Form 4 on record is dated 25 June 2026, one of 2 filings going back to 2025.